Form 4: Oncology Institute's Chief Medical Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Yale Podnos, Chief Medical Officer of Oncology Institute, sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 19, 2025, Yale Podnos, the Chief Medical Officer of Oncology Institute, Inc. (TOI), sold 2,975 shares of common stock.
- The sale was executed at a price of $0.889 per share.
- This transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
- Following the transaction, Podnos directly owns 69,993 shares of Oncology Institute's common stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes). It's neutral in sentiment as it doesn't indicate positive or negative developments for the company.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives. This transaction is a routine financial activity and doesn't necessarily reflect a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 03/19/2025 | Date of transaction: Yale Podnos sold shares of common stock. |
| 03/20/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Oncology Institute, Yale Podnos, Chief Medical Officer, Stock Sale, Restricted Stock Units, Tax Withholding, Beneficial Ownership, TOI
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.